BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30005848)

  • 21. Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens.
    Voss JS; Kipp BR; Halling KC; Henry MR; Jett JR; Clayton AC; Rickman OB
    Am J Respir Crit Care Med; 2010 Mar; 181(5):478-85. PubMed ID: 20007925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy.
    Shibuya K; Fujisawa T; Hoshino H; Baba M; Saitoh Y; Iizasa T; Suzuki M; Otsuji M; Hiroshima K; Ohwada H
    Lung Cancer; 2001 Apr; 32(1):19-25. PubMed ID: 11282425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.
    Feng M; Ye X; Chen B; Zhang J; Lin M; Zhou H; Huang M; Chen Y; Zhu Y; Xiao B; Huang C; Katz RL; Bai C
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2397-2405. PubMed ID: 33547948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytological findings of pre-invasive bronchial lesions detected by light-induced fluorescence endoscopy in a lung cancer screening system.
    Baba M; Iyoda A; Nomoto Y; Shibuya K; Hiroshima K; Saito H; Taguchi A; Kounoike K; Saegusa F; Kuwahara T; Tsujii H; Fujisawa T
    Oncol Rep; 2007 Mar; 17(3):579-83. PubMed ID: 17273736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The expression of survivin messenger RNA in sputum and cancerous tissue in human lung cancer].
    Chen YQ; Li DM; Cai YY; Liu C; Xia XM; Hu JF
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):225-9. PubMed ID: 15854429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.
    van 't Westeinde SC; Horeweg N; Vernhout RM; Groen HJM; Lammers JJ; Weenink C; Nackaerts K; Oudkerk M; Mali W; Thunnissen FB; de Koning HJ; van Klaveren RJ
    Chest; 2012 Aug; 142(2):377-384. PubMed ID: 22302298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost of diagnosis: a comparison of four different strategies in the workup of solitary radiographic lung lesions.
    Goldberg-Kahn B; Healy JC; Bishop JW
    Chest; 1997 Apr; 111(4):870-6. PubMed ID: 9106563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytodiagnosis of lung diseases].
    Atay Z; Grenze H; Schagen A
    Med Klin; 1970 Nov; 65(48):2097-100. PubMed ID: 4321990
    [No Abstract]   [Full Text] [Related]  

  • 30. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
    Hanas JS; Peyton MD; Lerner MR; Lightfoot SA; Deb SJ; Hanas RJ; Vu NT; Kupiec TC; Stowell DE; Brackett DJ; Dubinett SM; Hocker JR
    Cancer Invest; 2014 May; 32(4):136-43. PubMed ID: 24579933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.
    Varella-Garcia M; Kittelson J; Schulte AP; Vu KO; Wolf HJ; Zeng C; Hirsch FR; Byers T; Kennedy T; Miller YE; Keith RL; Franklin WA
    Cancer Detect Prev; 2004; 28(4):244-51. PubMed ID: 15350627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reevaluation of 201Tl-SPECT for patients with solitary pulmonary nodule--comparison study with biopsy method and tumor marker measurement].
    Nagamachi S; Jinnouchi S; Nishii R; Futami S; Tamura S; Matsuzaki Y; Onizuka T; Kawai K
    Kaku Igaku; 2001 Nov; 38(6):737-45. PubMed ID: 11806085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clincopathological variables to differentiate the nature of isolated pulmonary nodules in patients who received curative surgery for colorectal cancer.
    Chang TK; Tsai HL; Su WC; Huang CW; Yeh YS; Ma CJ; Wang JY
    Asian J Surg; 2019 Feb; 42(2):425-432. PubMed ID: 30262438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy.
    Okasaka T; Usami N; Mitsudomi T; Yatabe Y; Matsuo K; Yokoi K
    J Surg Oncol; 2008 Dec; 98(7):510-4. PubMed ID: 18802955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
    Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
    Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age, comorbidity, life expectancy, and pulmonary nodule follow-up in older veterans.
    Wong ML; Shi Y; Fung KZ; Ngo S; Elicker BM; Brown JK; Hiatt RA; Tang VL; Walter LC
    PLoS One; 2018; 13(7):e0200496. PubMed ID: 30044854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.
    Voss JS; Iqbal S; Jenkins SM; Henry MR; Clayton AC; Jett JR; Kipp BR; Halling KC; Maldonado F
    Hum Pathol; 2014 Jan; 45(1):41-7. PubMed ID: 24139213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
    Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for lung cancer.
    Midthun DE
    Clin Chest Med; 2011 Dec; 32(4):659-68. PubMed ID: 22054878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.